| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1300624A Medicine 'Wangyoujianbao' |
| 06/27/2001 | CN1067585C Mongolian medicine prescription for treating skin disease and preparation method thereof |
| 06/27/2001 | CN1067578C Chinese herb medicine allicin health-care liquid |
| 06/27/2001 | CN1067576C Medicine for burn and scald |
| 06/27/2001 | CN1067574C Traditional Chinese medicine preparation for treating leuoderma |
| 06/27/2001 | CN1067572C Sprayed powder for treating macerative erosive beriberi |
| 06/27/2001 | CN1067564C Medical ointment for burn and scald |
| 06/27/2001 | CN1067557C Tablet for promoting hair growth |
| 06/27/2001 | CN1067547C Cosmetics containing hydroquinone |
| 06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/26/2001 | US6251897 6-phenyltetrahydro-1,3-oxazin-2-one derivative and pharmaceutical composition containing the same |
| 06/26/2001 | US6251877 Topically administering to individual composition comprising purified beta-1,6-branched-beta-1,3-glucan from schizophyllum commune in amount effective to cause proliferation of skin cells |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251671 Culturing mammalian spermatogonial stem cells with bone morphogenetic protein 8 to cause proliferation of the stem cells and survival of spermatocytes |
| 06/26/2001 | US6251663 Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases |
| 06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
| 06/26/2001 | US6251371 Treatment of skin or mucosa inflammation by topical treatment with preparation containing dichlorobenzyl alcohol |
| 06/26/2001 | CA1341266C Combination of pyrimidine derivatives and antibacterial agents to induce and stimulate hair growth and reduce hair loss |
| 06/26/2001 | CA1341265C Combination based on pyrimidine derivatives and calcium antagonists to induce and stimulate hair growth and reduce hair loss |
| 06/21/2001 | WO2001045693A1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044455A2 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044294A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044227A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 06/21/2001 | WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044212A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043774A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043763A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | WO2001043756A2 Regenerative adjuvant |
| 06/21/2001 | WO2001043755A2 Regenerative adjuvant (3-way tap) |
| 06/21/2001 | WO2001043745A1 The use of scopolamine salts |
| 06/21/2001 | WO2001043716A1 Compositions for peeling |
| 06/21/2001 | WO2001043714A1 The use of fluorescent whitening agents |
| 06/21/2001 | WO2001043712A1 Catechol oximes and their use in cosmetic and dermatological preparations |
| 06/21/2001 | WO2001043711A1 Cosmetic skin conditioning compositions containing red yeast rice extract |
| 06/21/2001 | WO2001043704A1 A skin care composition that mediates cell to cell communication |
| 06/21/2001 | WO2001043701A2 Cosmetic or dermopharmaceutical compositions containing the n-palmytoyl-gly-hys-lys tripeptide |
| 06/21/2001 | WO2001043558A2 Reduced calorie fat compositions |
| 06/21/2001 | WO2001019871A3 Delivery system for antidandruff agent |
| 06/21/2001 | WO2001016136A3 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 06/21/2001 | US20010004639 Process for preparing arylacetylaminothiazoles |
| 06/21/2001 | US20010003851 Hair colorant composition containing phytantriol |
| 06/21/2001 | DE19960105A1 Catecholoxime und ihre Verwendung in kosmetischen und dermatologischen Zubereitungen Catecholoxime and their use in cosmetic and dermatological preparations |
| 06/21/2001 | DE19957318A1 Beeinflussung von TGF-Beta durch Proteolytische Enzyme Influence of TGF-beta by proteolytic enzymes |
| 06/21/2001 | CA2395486A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | CA2395119A1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents |
| 06/21/2001 | CA2394801A1 Regenerative adjuvant |
| 06/21/2001 | CA2394798A1 Regenerative adjuvant (3-way tap) |
| 06/21/2001 | CA2394576A1 Betaglycan as an inhibin receptor and uses thereof |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394544A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394538A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | CA2394536A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | CA2394431A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | CA2394167A1 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | CA2393972A1 Cyclopenteneone derivatives |
| 06/21/2001 | CA2393762A1 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | CA2392700A1 Reduced calorie fat compositions |
| 06/21/2001 | CA2390689A1 Human lyases and associated proteins |
| 06/21/2001 | CA2390674A1 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | CA2387047A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 06/21/2001 | CA2328586A1 Use of 3,3',5,5'-tetrahydroxystilbene as an anti-glycation agent |
| 06/20/2001 | EP1108417A2 Hair colorant composition |
| 06/20/2001 | EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 06/20/2001 | EP1108039A2 Elongase genes and uses thereof |
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1107973A1 Novel compounds |
| 06/20/2001 | EP1107963A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107959A2 Quinazoline derivatives as medicaments |
| 06/20/2001 | EP1107957A1 Pyrimidine compounds |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |